Interestingly, together with an inhibitor treatment, the IL-6 levels were no longer significantly increased, which is beneficial because elevated IL-6 serum levels can be considered as a precursor for serious hepatic diseases, such as hepatocellular carcinoma [47]. Here, IL6 is linked to hepatocellular carcinoma.